LOX and Alzheimer disease: It has been reported that COX, LOX, and CYP450, i.e., enzymes that break down EPA and the other five UFAs measured, have all been shown to be up-regulated in patients with AD [59,60], potentially explaining the decrease in the observed UFA species.